Fe3O4@MCM‐41@Zr‐MNPs modified with piperazine is easily prepared and characterized using Fourier transform infrared spectroscopy (FT‐IR), X‐ray powder diffraction (XRD), N2 adsorption–desorption, Transmission electron microscopy (TEM), Energy‐dispersive X‐ray (EDX), Vibrating sample magnetometry (VSM) and Thermogravimetric analysis (TGA) techniques. The characterization results showed that Zr highly dispersed in the tetrahedral environment of silica framework and piperazine is successfully attached to the surface of the nanocatalyst in connection with zirconium. The prepared nanosized reagent (10–30 nm), shows excellent catalytic activity in the synthesis of tetrahydro‐4H‐chromene and pyrano[2,3‐d]pyrimidinone derivatives. All reactions are performed under mild and completely heterogeneous reactions conditions in high yields during short reaction times. On the other hand and due to its superparamagnetic nature the catalyst can be easily separated by the application of an external magnetic field and reused for several times.
In the present study, we aimed to investigate the catalytic role of the newly reported MCM-41 -based nanocomposite in which the low acidity of this mesoporous moiety was favourably improved via the stabilization of zirconium nanoparticles and was magnetized to make a facile work-up
procedure as an applicable and efficient method. The prepared Fe3O4@MCM-41 @ZrCI2 nanocomposite was successfully characterized using different analyses and then it was favourably exploited for the synthesis of spirooxindoles as the most prominent spiro compounds.
As predicted, Fe3O4@MCM- 41 @ZrCI2 showed considerable efficiency in the promotion of the studied reaction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.